Osaic Holdings
ARCT icon

Osaic Holdings’s Arcturus Therapeutics ARCT Stock Holding History

Osaic Holdings’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75K Sell
1,451
-949
-40% -$7.48K ﹤0.01% 6625
2026
Q1 		$18.5K Buy
2,400
+443
+23% +$3.23K ﹤0.01% 5906
2025
Q4 		$12K Sell
1,957
-8,346
-81% -$90.1K ﹤0.01% 6224
2025
Q3 		$192K Buy
10,303
+8,140
+376% +$131K ﹤0.01% 4259
2025
Q2 		$28.1K Buy
2,163
+738
+52% +$8.73K ﹤0.01% 5451
2025
Q1 		$15.1K Buy
1,425
+364
+34% +$5.78K ﹤0.01% 5547
2024
Q4 		$18K Buy
1,061
+392
+59% +$7.38K ﹤0.01% 5417
2024
Q3 		$15.5K Sell
669
-1
-0.1% -$21 ﹤0.01% 5531
2024
Q2 		$16.3K Sell
670
-208
-24% -$6.31K ﹤0.01% 5480
2024
Q1 		$29.6K Sell
878
-94
-10% -$3.33K ﹤0.01% 5106
2023
Q4 		$30.6K Sell
972
-739
-43% -$17.6K ﹤0.01% 5231
2023
Q3 		$43.7K Buy
1,711
+41
+2% +$1.26K ﹤0.01% 5080
2023
Q2 		$47.9K Sell
1,670
-136
-8% -$3.7K ﹤0.01% 4968
2023
Q1 		$43.3K Sell
1,806
-175
-9% -$3.14K ﹤0.01% 5053
2022
Q4 		$33K Sell
1,981
-332
-14% -$5.79K ﹤0.01% 5219
2022
Q3 		$33K Sell
2,313
-138
-6% -$2.32K ﹤0.01% 5227
2022
Q2 		$37K Sell
2,451
-70
-3% -$1.37K ﹤0.01% 5173
2022
Q1 		$68K Sell
2,521
-606
-19% -$15.5K ﹤0.01% 4860
2021
Q4 		$116K Sell
3,127
-871
-22% -$35.5K ﹤0.01% 4460
2021
Q3 		$191K Sell
3,998
-487
-11% -$21.8K ﹤0.01% 3943
2021
Q2 		$151K Sell
4,485
-20,846
-82% -$706K ﹤0.01% 4113
2021
Q1 		$1.04M Buy
25,331
+20,508
+425% +$1.22M ﹤0.01% 2191
2020
Q4 		$209K Buy
4,823
+1,813
+60% +$123K ﹤0.01% 3444
2020
Q3 		$129K Buy
3,010
+1,263
+72% +$62.7K ﹤0.01% 3610
2020
Q2 		$82K Buy
1,747
+1,147
+191% +$39.5K ﹤0.01% 3833
2020
Q1 		$8K Buy
+600
New +$7.68K ﹤0.01% 5112

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Osaic Holdings's ARCT Position: Q2 2026 in Review

Osaic Holdings reduced its Arcturus Therapeutics (ARCT) stake by 40% in Q2 2026, selling an estimated $7.48K and leaving 1,451 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #6625.

Osaic Holdings first reported a position in ARCT in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.04M in Q1 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Osaic Holdings held 1,451 shares of Arcturus Therapeutics worth $9.75K as of Q2 2026.
  • Osaic Holdings sold 949 Arcturus Therapeutics shares in Q2 2026, an estimated $7.48K.
  • Arcturus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6625 holding.
  • Osaic Holdings first reported a position in Arcturus Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Arcturus Therapeutics position peaked at $1.04M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.